Cargando…
Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
OBJECTIVE: The aims of the present study were to analyze the association between discontinuation of paroxetine (PAX) and the genetic variants of the polymorphism in the serotonin transporter gene-linked polymorphic region (5-HTTLPR) in Japanese patients with panic disorder (PD) and major depressive...
Autores principales: | Aoki, Akiko, Ishiguro, Shin, Watanabe, Takashi, Ueda, Mikito, Hayashi, Yuki, Akiyama, Kazufumi, Kato, Kazuko, Inoue, Yoshimasa, Tsuchimine, Shoko, Yasui-Furukori, Norio, Shimoda, Kazutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174019/ https://www.ncbi.nlm.nih.gov/pubmed/25258536 http://dx.doi.org/10.2147/NDT.S68670 |
Ejemplares similares
-
Early Improvement and Marriage Are Determinants of the 12-Month Treatment Outcome of Paroxetine in Outpatients with Panic Disorder
por: Watanabe, Takashi, et al.
Publicado: (2017) -
PS213. Pharmacokinetics of mirtazapine and its hydroxylated metabolite in Japanese psychiatric patients treated with mirtazapine
por: Watanabe, Takashi, et al.
Publicado: (2016) -
Genetic Polymorphism of 1019C/G (rs6295) Promoter of Serotonin 1A Receptor and Catechol-O-Methyltransferase in Panic Disorder
por: Watanabe, Takashi, et al.
Publicado: (2017) -
The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder
por: Tomita, Tetsu, et al.
Publicado: (2014) -
Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders
por: Saruwatari, Junji, et al.
Publicado: (2014)